FREQUENCY OF HEPATITIS C VIRUS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AT TERTIARY CARE SETTINGS
PDF

How to Cite

Khan, A., Hayat, A., Shah, S., & Memon, S. (2015). FREQUENCY OF HEPATITIS C VIRUS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AT TERTIARY CARE SETTINGS. KHYBER MEDICAL UNIVERSITY JOURNAL, 7(3). Retrieved from https://www.kmuj.kmu.edu.pk/article/view/14011

Abstract

OBJECTIVE: To determine the frequency of hepatitis C virus infection in chronic obstructive pulmonary disease (COPD) at a tertiary care settings.

METHODS: This cross-sectional study was conducted at Liaquat University of Medical & Health Sciences Jamshoro form 10th April to 10th October 2013. Patients of either sex and ages form 30-65 years having COPD of at least three years who gave informed and written consent were enrolled. Blood samples of COPD patients were sent to hospital laboratory for detection of HCV antibodies via second generation ELISA. Patients having asthma, chronic liver disease, history of blood transfusion and surgical procedure in previous six months were excluded.

RESULTS: Mean age of enrolled participants was 44.41±3.5 years, ranging from 30-65 years. Male and female ratio was 1.8:1. Mean duration of illness was 3.55±0.222 years. Frequency of hepatitis C virus positivity in patients of COPD was 9(8.4%). Of 59 patients of 45 years of age were positive for HCV (p=0.153). Of 69 male patients, 3(4.3%) were positive for HCV compared to 6/38(15.8%) female patients (p=0.05). Comparing analysis of HCV positivity with regard to duration of COPD, 1/53 (1.9%) patients with duration of illness up-to 3.5 years was positive for HCV compared to 8/58 (14.8%) patients with duration of illness of >3.5 years (p=0.0017).

CONCLUSION: Frequency of hepatitis C virus positivity in COPD patients was 8.4%. Earlier and prompts treatment should be initiated to minimize HCV related morbidity.

KEY WORDS: Hepatitis C (MeSH), Chronic Obstructive Pulmonary Disease (MeSH), Chronic Obstructive Airway Disease (MeSH)

PDF

References

REFERENCE:

Feghali-Bostwick CA, Gadgil AS, Otterbein

LE, Pilewski JM, Stoner MW, Csizmadia

E. Autoantibodies in patients with chronic

obstructive pulmonary disease. Am J respire

Crit Care Med 2008;177(2): 156-63.

Casanova C, de Torres JP, Navarro J,

Aguirre-Jaíme A, Toledo P, et al. Microalbuminuria

and hypoxemia in patients with

chronic obstructive pulmonary disease.

Am J Respir Crit Care Med 2010; 182:

-10.

Tanveer A, Batool K, Qureshi AW: Prevalence

of hepatitis B and c in university

of the Punjab, Quaid-e-azam campus,

Lahore. J Agric Biol Sci 2008, 3:30-2.

Alianejad R, Ghanei M. Hepatitis C and

pulmonary fibrosis. Hepa Mon 201;

(2): 7-3.

Yearsley MM, Diaz PT, Knoell D, Nuovo

GJ. Correlation of HIV-1 detection and

histology in AIDS-associated emphysema.

Diagn Mol Pathol 2005; 14: 48-52.

Retamales I elliott WM Meshwi B. Amplification

of inflammation in emphysema and

its association with latent adenoviral infection.

Am J ResirCrit Car Med 200;164(3):

-73.

Kanazawa, H, Hirata, K, Yoshikawa, J.

Accelerated decline of lung function in

COPD patients with chronic hepatitis

C virus infection: a preliminary study

based on small numbers of patients.Chest

;123,596-9.

Silva DR, Stifft J, Cheinquer H, Knorst MM.

Prevalence of hepatitis C virus infection

in patients with COPD. Prevalence of

hepatitis C virus infection in patients with

COPD. 2010;138(2):167-73.

Serpil Erol, Leyla Sağslam, Ahmet Ozbek,

Ayten Kadanati,. Hepatitis C Virus Infection

and Chronic Obstructive Pulmonary

Disease. Hepatitis monthly 2009: 9();

-44.

Zignego AL, Ferri C, Pileri SA, Chaini P,

Bianchi FB. Extrahepatic manifestation of

Hepatitis C Virus infection: a general overview

and guidelines for clinical approach.

Dig Liver Dis 2007; 39(): 2-17.

Butt AA, Khan UA, McGinnis KA, Skanderson

M, KentKwoh C. Co-morbid medical

and pychiatric illness and substance abuse

in HCV-infected and uninfected veterans.

J Viral Hepat 2007;14(12): 890-6.

Erturk A, Tokgonul AN, Capan N, Erturk

H, Dursun AB, Bozkaya H et al. Pulmonary

alterations in patients with chronic HCV

infection. Dig Liver Dig Dis 2006;38(9):

-6.

Okuntan O, Kartaloglu Z, Ilvan A, Kutlu

A, Bozkanat E, Sili E, et al. Values of

high-resolution computed tomography

and pulmonary function tests in managements

of patients with chronic hepatitis

C virus infection. World J Gastroenterolv2004;

(3): 28-4.

Vincken W, Van Noord JA, Greefhorst

AP, Bantje TA, Kesten S, Korducki L, et al.

Improved health outcomes in patients with

COPD during 1 yr’s treatment with tiotropium.

Eur Respir J 2002;19(2):209-16.

Morissette MC, Vachon-Beaudoin G, Parent

J, Chakir J, Milot J. Increased p53 level,

Bax/Bcl-x(L) ratio, and TRAIL receptor

expression in human emphysema. Am J

Respir Crit Care Med 2008;178(3):240-7.

Work published in KMUJ is licensed under a

 Creative Commons Attribution-NonCommercial 2.0 Generic License.

Creative Commons License

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.